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Adenovirus 12 early region 1A (Ad12 E1A) was expressed in Escherichia coli. Protein was purified in good yield in the
presence of 8 M urea and then renatured by dialysis against dilute NH4HCO3 buffer. The affinity of this protein for pRb,
C-terminal binding protein (CtBP), TATA binding protein (TBP), and SUG1 was similar to, or greater than, that of Ad12 E1A
prepared by immunoaffinity chromatography under nondenaturing conditions. While the binding of the 266- and 235-amino-
acid (aa) E1A components to TBP showed similar characteristics the larger E1A protein had a higher affinity for CtBP, pRb,
and SUG1. Using nuclear magnetic resonance (NMR) spectroscopy it was shown that structural perturbations occurred in the
266-aa protein in the presence of Zn21 consistent with binding—no such changes were seen for the 235-aa protein. Limited
proteolysis of the 266- and 235-aa E1A proteins gave rise to comparable polypeptide products, suggesting overall similarities
in structure. However, the different affinities of the 266- and 235-aa proteins for the partner proteins and the differences seen
in the NMR spectra from the two proteins suggested structural differences. © 1998 Academic Press
INTRODUCTION
The adenovirus early region 1A (Ad E1A) gene en-
codes two major nuclear proteins which are identical
except for the presence of a short polypeptide [31 amino
acids in Ad12 and 46 amino acids (aa) in Ad5] located
toward the C-terminus of the larger molecule. The larger
(266 aa in Ad12 and 289 aa in Ad5) and smaller proteins
are translated from 13S and 12S mRNA species, respec-
tively (reviewed Boulanger and Blair, 1991; Bayley and
Mymryk, 1994).
Adenovirus E1A is a multifunctional protein producing
a number of varied effects in the host cell (reviewed,
Bayley and Mymryk, 1994; Moran, 1994; Williams et al.,
1995). It is a well-characterized transcriptional regulator,
being able to stimulate transcription from early adenovi-
rus promoters as well as a number of cellular promoters
(reviewed in Jones, 1995). This is accomplished through
binding to the DNA binding component of TFIID (TBP)
(Horikoshi et al., 1991; Lee et al., 1991) and to members
of the ATF family (Liu and Green, 1990; Flint and Jones,
1991; Chatton et al., 1993). Ad E1A stimulates entry of
quiescent cells into the cell cycle (Braithwaite et al.,
1985; Quinlan and Grodzicker, 1987) and suppresses
differentiation in a number of cell lines (Webster et al.,
1988; Maruyama et al., 1987). In addition, expression of
E1A can lead to cell immortalization and transformation
[generally but not always in the presence of cooperating
oncogenes (Bernards and van der Eb, 1984; Gallimore et
al., 1985)] or, under some circumstances, apoptosis (Rao
et al., 1992).
It now seems likely that all of these effects of E1A are
attributable to its interaction with host cell proteins such
as TBP and ATF-2, p105 retinoblastoma protein (Rb) and
the related p107 and p130, p300/CBP, which appears to
be a transcriptional coactivator, and the C-terminal bind-
ing protein (CtBP), which may also play a role in control
of transcriptional regulation (reviewed, Boulanger and
Blair, 1991; Bayley and Mymryk, 1994; Moran, 1994). The
sites of interactions with these and other binding pro-
teins are generally, although not exclusively, located in
regions conserved between E1As from different virus
serotypes (Moran and Mathews, 1987). Thus, for exam-
ple, the Rb family of proteins binds to E1A through con-
served regions (CR) 1 and 2 (amino acids 40 to 80 and
121 to 140, respectively, in Ad5) (Whyte et al., 1989) while
TBP interacts with the N-terminal portion of CR3 (amino
acids 139 to 189) (Lee et al., 1991; Horikoshi et al., 1991;
Geisberg et al., 1994). p300 binds to CR1 but also inter-
acts with a much less well conserved site very close to
the N-terminus of the protein (Yaciuk and Moran, 1991;
Wang et al., 1993). In addition to the well-characterized
CR1, 2, and 3 other highly conserved amino acid se-
quences are apparent in E1A such as those encoded by
exon 2. One of these, very close to the C-terminus of the
protein, has already been shown to be the site of inter-
action with the 48K C-terminal binding protein (Boyd et
al., 1993), while another is responsible for nuclear local-
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ization (Lyons et al., 1987). Interaction of Ad E1A with a
number of other proteins for which binding sites are, as
yet, unknown has been reported. For example, Ad5 E1A
binds to the cell cycle regulator p27 (Mal et al., 1996a)
and the mammalian 26S proteasome regulatory compo-
nent SUG1 (Grand et al., submitted for publication). This
latter protein is multifunctional, as it has also been
shown to possess DNA helicase activity (Fraser et al.,
1997), bind to c-Fos (Wang et al., 1996) and TBP (Swaf-
field et al., 1995), and act as an intermediary in nuclear
thyroid receptor signaling (Lee et al., 1995).
In spite of the wealth of published data on the binding
of cellular proteins to Ad E1A, virtually no information is
available on the structural basis or consequences of
these interactions. With this in mind, we have initiated a
study of the structure of Ad12 E1A using nuclear mag-
netic resonance spectroscopy. This obviously requires
the expression and purification of large quantities of
biologically active protein. Ideally, the expressed protein
would be purified under mild, nondenaturing conditions
to keep secondary and tertiary structures intact and
retain full activity. However, together with a number of
other groups, we have found that yields of pure soluble
protein, even after overexpression in bacteria, insect
cells, or yeast, are poor. Therefore, we demonstrate here
that the Ad12 E1A proteins, prepared in high yield under
denaturing conditions, can be renatured so that they are
capable of interacting with several binding partners as
well as Zn21. In addition, we show that the folded con-
formations adopted after renaturation of the 266- and
235-amino-acid proteins have certain basic similarities
but are not identical.
RESULTS
Preparation of Ad12 E1A proteins
Ad12 E1A 235- and 266-aa proteins were expressed in
Escherichia coli. These proteins were predominantly in-
soluble under nondenaturing conditions, but could be
solubilized in the presence of 8 M urea. Most contami-
nating, bacterial proteins were removed by differential
precipitation with increasing concentrations of ethanol. A
similar procedure has been used previously to purify
other small, acidic proteins such as calmodulin (Grand et
al., 1979) and myosin light chains (Perrie and Perry, 1970).
Remaining impurities were removed by ion exchange
chromatography. Results of a typical purification are
shown in Fig. 1A. Usually, yields of 15–20 mg of the Ad12
266-aa component from a 3-liter culture of E. coli were
obtained. Yields of the Ad12 235-aa protein were appre-
ciably lower (around 6 mg from a 3-liter culture) for
reasons which are not clear at present (Fig. 1B). Urea
was removed from the purified Ad12 E1A by prolonged
dialysis against 10 mM NH4HCO3 in the cold. Proteins
were subjected to a final desalting step using Sephadex
G25 eluted with 10 mM NH4HCO3.
Ad12 E1A 266-aa protein was also prepared under
nondenaturing conditions by immunoaffinity chromatog-
raphy after expression in E. coli, as described under
Materials and Methods. Yields were appreciably lower
(1–2 mg from a liter culture) because a proportion of the
bacterially expressed E1A was insoluble (and was there-
fore not available for purification) and because of the
limitations on the binding capacity of the ‘‘antibody affinity
column.’’ This protein was considered ‘‘native.’’
Interactions of Ad12 E1A proteins
As E1A has no known enzymic activity, novel criteria
had to be applied to the protein to assess whether the
purified bacterially expressed E1A renatures, following
removal of the urea buffer. Therefore the ability of the
E1A proteins to interact with known partner proteins was
determined using ELISA techniques.
Four GST-linked fusion proteins were expressed in
bacteria. GST-TBP, GST-CtBP, GST-pRb105 (a fragment
encompassing the E1A binding site), and GST-SUG1
were purified to homogeneity by affinity chromatography
using glutathione–agarose. In the first set of experiments
purified Ad12 E1A (either 266- or 235-aa proteins) was
bound to ELISA plates. Increasing concentrations of fu-
FIG. 1. Purification of Ad12 E1A 266-aa protein. (A) Coomassie blue-
stained polyacrylamide gel of fractions obtained during the purification
of Ad12 E1A after expression in E. coli. 50 mg of protein was electro-
phoresed in each case. Lane 1, E. coli expressing Ad12 E1A; 2, protein
soluble in 8 M urea buffer; 3, protein insoluble in 8 M urea buffer; 4,
protein precipitated with 50% ethanol; 5, protein precipitated with 70%
ethanol; 6, protein precipitated with 85% ethanol; 7, Ad12 E1A after
purification by ion exchange chromatography. (B) Western blot of puri-
fied Ad12 E1A. Three preparations of Ad12 E1A were purified as
described under Materials and Methods and then subjected to Western
blotting using rat polyclonal antibody against Ad12 E1A. A similar
proportion of the original total E. coli extract was electrophoresed in
each case. Lanes 1 and 2, Ad12 E1A 266-aa proteins (two separate
preparations); 3, Ad12 E1A 235-aa protein.
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sion proteins were then added. After incubation and
washing, the amount of bound interacting species was
determined using an antibody against GST. The absorp-
tion (expressed as a percentage of that observed at the
highest concentration of binding protein, which in most
cases corresponds to an end point of the binding reac-
tion) was plotted against concentration of binding protein
added. Standard Scatchard analysis was performed on
the data and is shown as an inset panel in each case. It
can be seen from Figs. 2A and 2B that an interaction
between both Ad E1A 266- and 235-aa proteins and
GST-CtBP and GST-pRb could be demonstrated. Binding
of the two Ad12 E1A components to SUG1 could also be
seen (data not shown). Only very slight binding to the
myosin light chain (a control protein of similar size and
charge to E1A) could be seen. Adjustment was, however,
made to the values obtained for binding of E1A to the
fusion protein to take account of this.
Interaction of Ad12 E1A with TBP was not unequivo-
cally demonstratable when this approach was adopted.
However, when varying concentrations of the fusion pro-
tein were bound to the ELISA plate and E1A was added
strong binding was observed (Fig. 3A). (Data are ex-
pressed in a manner similar to that described for Fig. 2).
Binding of Ad12 E1A to GST-SUG1 was also confirmed
using this approach (i.e., the fusion protein bound to the
ELISA plate) (Fig. 3B). Control ELISAs were also carried
out in which GST HPV1 E4 was immobilized on the plate
and the binding of Ad12 E1A measured. The low back-
ground levels observed have been subtracted from the
data presented in Fig. 3. We presume that a strong
complex of E1A with GST-TBP could not be shown when
the viral protein was used to coat the ELISA plate be-
cause this binding to the plastic masked, or altered the
conformation of, the site of interaction on E1A. Addition-
ally, final detection using a monoclonal antibody (against
E1A) reduced the nonspecific background reactivity and
increased the sensitivity of the method.
The data shown in the Scatchard analyses in Figs. 2
and 3 were used to calculate dissociation constants for
the binding of fusion proteins to Ad12 E1A 266- and
235-aa proteins (Table 1). In each case, the affinity of the
larger E1A component, for the partner protein, was
higher, although in the case of TBP and probably SUG1
not significantly so. Interaction with pRb appears to be
weaker than with the other binding proteins but this may
well be attributable to the fact that the construct used
only encoded a portion of the pRb sequence and that the
E1A was not phosphorylated [Mal et al., (1996b) have
shown that phosphorylation of Ad E1A increases its
affinity for pRb]. (Although the truncated pRb contains the
full E1A binding site, it is quite possible that it folds
anomalously, reducing its affinity for E1A.) The straight
lines obtained from the Scatchard plots for CtBP, TBP,
SUG1, and pRb indicate a single site of interaction on
both Ad E1A and the interacting protein.
As an indication of the extent to which A12 E1A,
prepared in the presence of urea and ethanol, had
been renatured, its ability to bind partner proteins was
compared with material prepared under nondenatur-
ing conditions by immunoaffinity chromatography
(eluted at pH 7.0 with ‘‘Pierce buffer’’). The results of
FIG. 2. Binding of Ad12 E1A to CtBP and pRb. Ad12 E1A 266- and 235-aa proteins were immobilized on microtiter plates. Various concentrations
of GST-CtBP and GST-pRb were added and the proportion of bound fusion protein was determined using an antibody against GST, as described under
Materials and Methods. Concentrations of (A) CtBP and (B) pRb added were plotted against bound protein. (--f--) Ad12 E1A 266-aa protein. (©) Ad12
E1A 235-aa protein. Scatchard analyses were carried out on these data and are shown as inset panels.
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typical ELISAs using 266-aa Ad12 E1A proteins are
presented in Fig. 4. Thus, it can be seen that in all
cases the denatured/renatured protein bound to CtBP,
mSUG1, and TBP at least as well as, and usually better
than, the ‘‘native’’ Ad12 E1A.
It is, of course, possible that Ad E1A will interact with
partner proteins regardless of its previous treatment—
i.e., it is relatively unstructured in vivo and is never really
denatured. The data presented in Fig. 4 suggest that this
is not the case since ‘‘native’’ E1A tended to bind mSUG1
and TBP rather less well than the protein prepared in the
presence of urea. However, to address this point in more
detail Ad12 266-aa protein (after preparation under de-
naturing conditions and subsequent renaturation) was
incubated in the presence of 5% SDS for 5 min at 50°C
and then dialyzed against dilute phosphate buffer to
remove excess SDS. This material was used in a further
set of ELISAs in which binding to partner proteins was
determined. It can be seen from the data presented in
Fig. 5 that pretreatment of E1A with SDS reduced its
ability to bind to mSUG1 and TBP by well over 50% and
to pRb by over 30%. Binding to CtBP was hardly affected.
These results are consistent with the data presented in
Fig. 4 which suggested that some treatment of Ad E1A
gave rise to protein with a reduced ability to interact with
mSUG1 and TBP. We suggest that this is equivalent to
(perhaps partial) denaturation resulting in disruption of
binding sites. When the ELISAs were carried out using
very high concentrations of Ad E1A the SDS-denatured
protein gave comparable results to the renatured mate-
rial, perhaps suggesting that weak interactions occurred
with the partner proteins even without complete regen-
eration of the native conformation.
We conclude that, on this basis, the ethanol/urea de-
naturation procedure did not cause irreversible disrup-
tion to the secondary structure of E1A and that removal
of the denaturant resulted in refolding to give a structure
which was recognized and bound by the partner pro-
teins. It is interesting to note that Ad12 E1A eluted from
the immunoaffinity columns using Pierce buffer had a
slightly higher affinity for the binding proteins than that
eluted at pH 3.0 (data not shown). We conclude that
exposure to low pH has a deleterious effect on the
structure of the protein which is not easily reversible.
Ad12 E1A 266-aa protein was also compared with Ad5
E1A 289-aa protein (prepared under native conditions)
for its ability to bind to CtBP and little difference could be
FIG. 3. Binding of Ad12 E1A to TBP and SUG1. Various concentrations of GST-TBP and GST-SUG1 were immobilized on microtiter plates. Ad12 E1A
266- and 235-aa proteins were added and the amount bound was determined using an antibody against Ad12 E1A, as described under Materials and
Methods. Concentrations of (A) TBP and (B) SUG1 were plotted against bound Ad12 E1A. (--f--) Ad12 E1A 266-aa protein. (©) Ad12 E1A 235-aa
protein. Scatchard analyses were carried out on these data and are shown as inset panels.
TABLE 1
Affinity of Ad12 E1A for E1A Binding Proteins
Protein
Kd (10
29 M)
E1A 266 aa (13S) E1A 235 aa (12S)
CtBP 3.8 13.3
SUG1 14.9 24
TBP 4.0 5.8
pRb 60.7 102
Note. Dissociation constants were calculated from Scatchard anal-
ysis and 1:1 stoichiometry was observed in every case.
233BINDING PROPERTIES OF ADENOVIRUS 12 E1A PROTEINS
observed (Fig. 4D), confirming, for this binding protein at
least, that the Ad12 component had renatured correctly.
Zn21 binding to the 266-aa Ad12 E1A protein
It has long been established that the larger Ad5 E1A
protein strongly binds Zn21 in vivo through a four-cys-
teine motif in CR3 (Culp et al., 1988). This amino acid
sequence is absent from the Ad5 E1A 243-aa protein. To
demonstrate a similar interaction for the Ad12 E1A
266-aa component, an NMR spectroscopic approach
was adopted. Purified 266- and 235-aa E1A proteins
were incubated with increasing concentrations of ZnCl2
as described under Materials and Methods. Very few
changes could be seen in the aromatic region of the 1H
NMR spectra obtained from the 235-aa protein in the
presence of Zn21 (Fig. 6A). No significant differences
could be seen in the upfield region of the spectrum,
associated with aliphatic amino acids on the addition of
Zn21 (data not shown). However, when Zn21 was added
to the E1A 266-aa protein a number of specific changes
were observed in the spectrum (Fig. 6B) which we at-
tribute to local structural perturbations resulting from
metal ion binding. Again, the aromatic portion of the
spectrum is shown. Signals which are significantly
changed on the addition of the metal ion are marked with
arrows, most notably the singlet resonance of a histidine
FIG. 4. Comparison of the binding properties of Ad12 E1A 266-aa proteins prepared under ‘‘native’’ and denaturing conditions. Microtiter plates were
coated with (A) GST-SUG1; (B) GST-TBP; (C) Ad12 E1A; and (D) Ad12 E1A 266-aa protein or Ad5 E1A 289-aa protein. The amount of bound partner
protein was determined as described under Materials and Methods. Thus, for A and B, Ad12 E1A 266-aa ‘‘native’’ (v) or ‘‘denatured/renatured’’ (f) was
added; for C, GST-CtBP was added and the amount bound to native (v) and denatured/renatured (f) Ad12 E1A is shown; for D, GST-CtBP was added
and the amount bound to Ad12 E1A 266-aa (f) and Ad5 E1A 289-aa () protein is shown.
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C4 proton labeled (a) which broadens significantly in the
presence of Zn21. This most likely represents an aver-
aging of the spectral signal due to fast exchange be-
tween the metal ion-bound and metal ion-free conform-
ers of the 266-aa protein. Other perturbations were evi-
dent in the upfield region of the spectrum (data not
shown). As expected, comparison of the spectra ob-
tained for the 266- and 235-aa proteins shows some
differences (Fig. 6C). Whether these are explicable on
the basis of the extra 31 amino acids from CR3 or are due
to differences in the global structures of the two E1A
proteins remains to be established.
Limited proteolysis of Ad12 E1A 266- and 235-aa
proteins
Data obtained from the NMR study of the two Ad12
E1A proteins suggested there might be some structural
differences between them. In an attempt to determine
how profound these differences were, both of the pro-
teins were subjected to limited proteolysis. At low con-
centrations proteases will preferentially cleave suscep-
tible peptide bonds that are exposed in the folded protein
substrate. Thus, Ad12 E1A 266- and 235-aa proteins
were incubated with V8 protease or chymotrypsin. Ali-
quots were withdrawn at appropriate times and fraction-
ated on polyacrylamide gels.
Western blots obtained using polyclonal sera against
Ad12 E1A are shown in Fig. 7. (Staining of gels with
Coomassie blue gave identical patterns to those pre-
sented in Fig. 7—data not shown.) There is a marked
similarity between the patterns seen following digestion
of the 266- and 235-aa proteins. To confirm that cleavage
of the two proteins gave rise to similar peptides, amino
acid sequence analysis was carried out after purification
on polyacrylamide gels. It can be seen from the data
presented in Table 2 that the major products obtained
from the 266- and 235-aa proteins had similar N-terminal
sequences. The overall composition of the peptides was
obtained by amino acid analysis, allowing us to predict
the approximate dimensions of the polypeptides (Table
2). The major difference seen between the two Ad E1A
proteins (Fig. 7) is attributable to a peptide (C5) produced
after digestion with chymotrypsin. This peptide spans
residues 185 to the C-terminus of the 266-aa protein. This
cleavage site is, of course, absent from 235-aa protein as
it occurs in the unique portion of CR3. Thus, no peptide
equivalent to C5/5A was obtained from the 235-aa pro-
tein. It can also be seen that similar, although not iden-
tical, proteolytic patterns were obtained when ‘‘native’’
Ad12 E1A 266-aa protein was incubated with chymotryp-
sin and V8 protease (Fig. 7). This suggests a similar
overall structure, as the two proteins were susceptible to
similar concentrations of protease. The differences be-
tween the ‘‘native’’ (Fig. 7, panel 3) and renatured (Fig. 7,
panel 1) E1A degradation patterns may presumably rep-
resent slight differences in structure but it seems likely
that the native protein is more susceptible to degrada-
tion, as no peptides equivalent to C5/5a were seen.
Reasons for this are not clear but this result is consistent
with the weaker binding of native E1A to the partner
proteins (Fig. 4).
The large proteolytic fragments of E1A cover interac-
tion sites for some of the well-characterized binding
proteins. To assess whether these polypeptides were
still capable of forming complexes, digests of E1A were
fractionated on 15% polyacrylamide gels in the presence
of SDS and then transferred to nitrocellulose mem-
branes. Filters were incubated with GST-TBP, GST-Rb,
GST-SUG1, or GST-CtBP as described under Materials
and Methods, although no attempt was previously made
to renature the E1A peptides. Bound protein was de-
tected with an antibody against the GST moiety. It can be
seen from the blot shown in Fig. 8 that CtBP binds to
those fragments previously identified as containing the
C-terminal amino acids of E1A [previously established as
the binding site (Boyd et al., 1993)]. When similar mem-
brane filters were incubated with the other fusion pro-
teins, no binding was detected—even to full-length E1A
(data not shown). We have concluded that in this case
FIG. 5. Binding of denatured Ad12 E1A to partner proteins. GST-
SUG1, GST-TBP, and GST-pRb were immobilized on microtiter plates.
Renatured (solid columns) or previously SDS-denatured (hatched col-
umns) Ad12 E1A 266-aa proteins were added and the amount of bound
E1A was determined using the monoclonal antibody 5D02. In the case
of GST-CtBP, Ad12 E1A was immobilized on the ELISA plate and
GST-CtBP added. The amount bound was determined with an antibody
against GST. Data presented were obtained with binding proteins at
concentrations of 2.5, 3, 0.4, and 50 mg/ml for GST-SUG1, GST-CtBP,
GST-TBP, and GST-pRb, respectively.
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FIG. 6. Zn21 binding to Ad12 E1A shown by 1H nuclear magnetic resonance spectroscopy. The spectral regions associated with aromatic side chains
are shown in each case. Spectra were obtained as described under Materials and Methods. (A) Ad12 E1A 235-aa protein (0.9 mg/ml) (i) before and (ii) after
addition of a stoichiometric concentration of ZnCl2. (B) Ad12 E1A 266-aa protein (2 mg/ml) (i) before and (ii) after the addition of a stoichiometric concentration
of ZnCl2. Resonances attributable to the side chains of F and Y are indicated. Resonances which are considered to change significantly on addition of Zn
21
are indicated ( ). (C) Comparison of the spectra obtained for (i) Ad12 E1A 235-aa protein and (ii) Ad12 E1A 266-aa protein in the presence of Zn21.
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renaturation did not occur. This observation is consistent
with the data presented in Fig. 5, which suggests that
without renaturation binding of Ad E1A to TBP, Rb, and
SUG1 is appreciably impaired.
DISCUSSION
We have described here a simple novel procedure for
the preparation of relatively large quantities of Ad12 E1A
266- and 235-amino-acid proteins. This protocol is based
on precipitation of the protein from solution in 8 M urea
by the addition of high concentrations of ethanol. In the
past a similar approach has been adopted for the puri-
fication of other small acidic proteins such as calmodulin
(Grand et al., 1979) and myosin light chains (Perrie and
Perry, 1970). In these cases removal of the denaturant
FIG. 7. Limited proteolysis of Ad12 E1A. Renatured Ad12 E1A 266 (1)-,
renatured Ad12 E1A 235 (2)-, or ‘‘native’’ Ad12 E1A 266 (3)-aa proteins were
incubated with chymotrypsin or V8 protease as described under Materials
and Methods. Aliquots were withdrawn at the times indicated and sub-
jected to PAGE and Western blotting, as shown. The major peptide prod-
ucts in panels 1 and 2 are indicated and were identified by amino acid
sequencing and amino acid analysis. These data are presented in Table
2. The prefix C indicates peptides obtained following proteolysis with
chymotrypsin and prefix V peptides obtained following proteolysis with V8.
TABLE 2
Major Peptide Fragments Identified after Limited
Proteolysis of Ad12 E1A
Peptide N-terminal sequence
Approximate dimensions
(residue numbers)
Ad12 266-aa
protein
V1 MRTEM and MTPLV 1–266 and 5–266
V3 GLFLP 76–266
V4 MGFPC 112–266
V5 GVIKP 221–266
C1 MRTEM 1–ND
C2 VLSYQ 9–266
C3 ELYDL 43–266
C5/5A NMFIY and IVSPV 185–266 and 188–266
Ad12 235-aa
protein
Va MTPLV 5–235
Vb SLILA 68–ND
Vc GLFLP 76–235
Vd GVIKP 189–235
Ca/b MRTEM and VLSYQ 1–ND and 9–ND
Cc ELYDL 43–235
Cd EMGFP 111–235
Note. The prefices V and C denote peptides produced after cleavage
with V8 protease and chymotrypsin, respectively. ND, not determined.
FIG. 8. Binding of CtBP to Ad12 E1A fragments. Ad12 E1A 266-aa
protein was digested with chymotrypsin or V8 protease, as described
under Materials and Methods, fractionated by SDS–PAGE, and then
transferred to a nitrocellulose filter. The filter was incubated with
GST-CtBP. Bound GST-CtBP was visualized as described under Mate-
rials and Methods. Peptides obtained after digestion with chymotrypsin
and V8 are designated C and V, respectively, and correspond to pep-
tides shown in Fig. 7 and identified in Table 2.
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lead to recovery of biological activity and presumably full
structural integrity. We therefore considered that Ad12
E1A prepared in this way could be ‘‘renatured’’ after
dialysis against dilute nondenaturing buffer.
The ability of Ad12 E1A, after renaturation, to interact
with known partner proteins was examined using
ELISAs. We have recently demonstrated that Ad E1A can
be immunoprecipitated in a complex with SUG1 from
both Ad5 E1 and Ad12 E1 transformed cells (Grand et al.,
submitted for publication). SUG1 has been shown to be
a regulatory component of the 26S proteasome, to inter-
act with c-Fos, and to have homology to SUG1 from yeast
(Wang et al., 1996; Rubin et al., 1996). Recently, it has
been demonstrated to possess DNA helicase activity
(Fraser et al., 1997). Here we demonstrate a direct inter-
action of both the Ad12 266- and 235-amino-acid com-
ponents in the absence of other proteins (Fig. 3). The
larger E1A protein had a slightly higher affinity for SUG1
(Table 1), although the significance of this is not clear at
present.
When binding to the well-characterized partner pro-
teins, it was considered that the 266- and 235-aa E1A
components bound GST-TBP with equal affinity. This was
unexpected as it has previously been shown in Ad5 E1A
that the TBP binding site is located in the amino acid
sequence unique to the larger 289-aa E1A and does not
occur in the 243-aa protein (Lee et al., 1991; Webster and
Ricciardi, 1991; Geisberg et al., 1994). However, we have
previously presented evidence that in Ad12 E1A the TBP
binding site is in that portion of CR3 which occurs in both
the 266- and 235-aa proteins (Molloy et al., submitted for
publication) and probably involves a helical configuration
which stretches at least from amino acids alanine 139 to
histidine 151. The data presented in Fig. 3A are consis-
tent with this view.
It is not clear why, in the experiments presented here,
the 235-aa E1A component has a lower affinity for CtBP
and pRb (Fig. 2 and Table 1) than the 266-aa homologue,
as the binding sites for the two partner proteins are
present in both [at the C-terminus and in CR1 and CR2,
respectively (Boyd et al., 1993; Whyte et al., 1989)]. It is
possible that the 235-aa protein does not bind pRb or
CtBP as well as the 266-aa E1A in vivo (although no
evidence has previously been presented to suggest this)
or that the 235-aa protein does not renature as well as
the larger E1A protein after purification in urea. These
possibilities cannot be differentiated at present. It should
be borne in mind, however, that both of these partner
proteins are linked to GST moieties which could affect
binding and that the pRb construct used only encodes a
portion of the protein—it is possible that this modified
pRb binds Ad12 235-aa protein rather weakly even
though the full-length pRb interacts with the 266- and
235-aa proteins to a similar extent. The observation that
renatured Ad12 E1A binds the partner proteins at least
as well as E1A prepared by immunoaffinity chromatog-
raphy confirms that the preparation and renaturation
procedures outlined here are capable of producing pro-
tein with a structure comparable to that present in un-
denatured E1A after expression in E. coli and perhaps
comparable to that present in vivo. It should be noted,
however, that steps were not taken to optimize the rena-
turation process. Thus it is possible that by varying the
buffer conditions, time of renaturation, and temperature
Ad12 E1A might have been produced with a higher af-
finity for the partner protein—this point will be ad-
dressed in future studies.
The calculated dissociation constants for E1A binding
to the partner proteins are all in the low nanomolar range
(Table 1). This is consistent with values obtained for
many other well-characterized protein–protein interac-
tions, such as troponin I binding to troponin C, actin to
myosin, rhodopsin to Gta, as well as the binding of EF-Tu
to aminoacyl tRNA. Obviously, the experiments de-
scribed here are not representative of the in vivo situa-
tion as the E1A is exposed to a single binding protein at
a time. In the cell it is probable that interaction with one
protein will affect the affinity of E1A for other potential
partners. This possibility is currently under investigation.
From the Scatchard analysis (Figs. 2 and 3) it appears
that there are single sites of interaction on both E1A and
the partner proteins. This is in agreement with published
data for TBP (Geisberg et al., 1994) and CtBP (Boyd et al.,
1993) but not for pRb which binds to Ad E1A through CR1
and CR2 (Whyte et al., 1989). This discrepancy could well
be explained by the use of the truncated pRb protein
linked to GST as noted above. A single binding site for
GST-pRb was also calculated for native Ad12 E1A (data
not shown). No information is available on the interaction
site for SUG1 on Ad E1A.
Native Ad5 E1A 289-aa protein binds 1 mol of Zn21
(Culp et al., 1988), although after the preparation proce-
dure described here no metal ions could be detected
associated with Ad12 E1A 266-aa protein; presumably
they are removed during the denaturation in 8 M urea
and ethanol. When Zn21 was added back to the protein,
perturbations in the NMR spectrum were observed con-
sistent with changes in local protein structure which
might follow binding. This supports our contention that
after preparation E1A renatured on removal of the urea.
The observation that there were no changes in the spec-
trum of Ad12 E1A 235-aa protein following addition of
Zn21 was as expected and confirms that metal ion bind-
ing to the 266-aa protein was specific and presumably
biologically significant. Overall differences in the NMR
spectra obtained for the 266- and 235-aa proteins are
obviously, at least in part, attributable to the additional 31
CR3 amino acids in the larger molecule. It is possible,
however, that there are other differences in the spectra
which may suggest overall differences in folding of the
266- and 235-aa proteins.
Limited proteolysis of the two E1A proteins gave rise
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to comparable patterns of digestion with the major pep-
tide products being of similar dimension (Figs. 7 and 8
and Table 2). Thus, it appears that the C-terminal region
is resistant to degradation and presumably highly struc-
tured since as proteolysis proceeds there is a progres-
sive loss of sequence from the N-terminus, leaving only
C-terminal peptides intact (Fig. 7 and Table 2). It seems
likely that those amino acid sequences particularly sus-
ceptible to proteolysis derive from regions of the protein
that adopt intrinsically ‘‘open’’ conformations or are on the
surface of the protein, allowing easy access to the chy-
motrypsin or V8 protease molecules. On this basis it
might be suggested the C-terminal region is highly struc-
tured or deeply buried in the protein structure, allowing
the accumulation of peptides (C5 and V5) after treatment
with either protease even when further degradation is
possible (i.e., susceptible cleavage sites are still
present). It appears that most of CR1 is also resistant to
degradation as fragments (V3, Vc, C3, and Cc) have been
isolated which commence at the N and C termini of CR1
but not from the major central portion where susceptible
bonds are also available. It is also interesting to note that
a peptide was isolated after V8 treatment (V4) commenc-
ing close to the N-terminus of CR2 but no peptides were
seen which ran from the numerous glutamic acid resi-
dues N-terminal to this. We suggest that CR2, the ‘‘onco-
genic spacer’’ region, and the N-terminus of CR3 also
form a highly structured domain. This could well be
helical, extending from the polyalanine sequence (resi-
dues 134–139) in the ‘‘oncogenic region’’ which would be
predicted to form an a helix (Marqusee et al., 1989;
Chakrabartty et al., 1991).
These data, together with the NMR spectra shown in
Fig. 6, strongly suggest that Ad12 E1A like most, perhaps
all, other proteins has a well-defined three-dimensional
structure in solution and is not, as has been suggested
(Bayley and Mymryk, 1994), merely a flexible amino acid
sequence which only readily adopts a secondary and
tertiary structure when bound to a partner protein. The
inability of pRb, TBP, and SUG1 to bind full-length or
proteolytic fragments of Ad12 E1A after electrophoresis
in the presence of SDS is consistent with this view, as is
their reduced affinity for SDS-denatured Ad E1A (Fig. 5).
We conclude that the presence of the E1A amino acid
sequence comprising a binding site for these proteins is
not alone sufficient to ensure an interaction. Efficient
renaturation and refolding of the binding site is essential.
This does not appear to apply to the CtBP which binds
the C-terminal fragment of Ad12 E1A strongly, even on
the nitrocellulose membrane (Fig. 8). It is possible that
this complex formation is attributable to the fact that
these E1A fragments do not become totally denatured
even after SDS–PAGE, as evidenced by the highly anom-
alous migration pattern on the gel (apparent molecular
weights of 14.5 and 11.6K for C5 and V5 compared to the
actual molecular weight of 9137 and 5269, respectively).
The possibility exists that some of the Ad12 E1A protein
used in these experiments renatured, leaving the re-
mainder in a denatured, random state. However, the
well-defined NMR spectra shown in Fig. 6 certainly sug-
gest that the majority of the protein is not denatured and
the derived dissociation contants and binding data are
consistent with a relatively homogeneous population of
‘‘native’’ protein, although the presence of small amounts
of still denatured material cannot be discounted.
The observation that Ad E1A can still be biologically
active following denaturation is not novel. Indeed, in the
initial descriptions of Ad E1A expression in E. coli it was
shown that even after preparation in the presence of
denaturants the protein was able to stimulate adenovirus
gene expression after microinjection into appropriate
cells (Ferguson et al., 1984; Krippl et al., 1984). Since
those early studies much effort has been devoted to
perfecting procedures for the purification of E1A under
nondenaturing conditions (see, for example, Bruner et
al., 1988; Patel and Jones, 1990; Peeper et al., 1992).
Unfortunately, none of the methods appear to be capable
of producing enough material to enable serious struc-
tural studies to be undertaken. The data presented here
suggest that these problems can be overcome by the
straightforward renaturation of Ad E1A after expression
in E. coli and that material adopts a conformation ap-
proximating that found in the native protein. Even if re-
naturation is not total we consider that the studies pre-
sented here and our planned NMR study are important
first steps in understanding the structure of Ad E1A.
MATERIALS AND METHODS
Preparation of Ad12 E1A 235- and 266-aa proteins
under denaturing conditions
Ad12 E1A DNA was cloned into pKK 388-1. Ad12 235-
and 266-aa proteins were expressed in E. coli TG2.
Three hours after induction with ITPG bacteria were
harvested, centrifuged, and washed in PBS. Pellets were
resuspended in 10 vol of 8 M urea, 15 mM Tris–HCl, pH
7.4, 15 mM b-mercaptoethanol (buffer A), sonicated for
30 s, and centrifuged at 10K for 20 min. The pellet was
discarded. An equal volume of ethanol was slowly added
to the supernatant with constant stirring. After 10 min
precipitated proteins were pelleted by centrifugation at
5K for 15 min and discarded. The ethanol concentration
of the supernatant was increased to 70%. Again, precip-
itated proteins were removed by centrifugation at 5K for
15 min and discarded. Finally, E1A was precipitated by
increasing the ethanol concentration to 85%. This protein
was collected by centrifugation, redissolved in buffer A
(15 ml), and dialyzed against buffer A. The remaining
contaminants were removed from the E1A by chroma-
tography on a column (6 3 1 cm) of DEAE–cellulose
equilibrated in buffer A. E1A was eluted with a gradient
of NaCl (0 3 0.25 M) and was detected by Western
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blotting (see below). Fractions containing E1A were
pooled, dialyzed exhaustively against 10 mM NH4HCO3,
0.1 mM b-mercaptoethanol in the cold, and then freeze
dried. Ad E1A was finally desalted on a column of Seph-
adex G25 and stored at 270°C.
Preparation of Ad12 E1A 235- and 266-aa proteins by
immunoaffinity chromatography
Generation of a-E1A immunoaffinity columns. Anti-E1A
mouse monoclonal antibody (170/3) (Gash, Grand, and
Gallimore, unpublished data) was purified from mouse
hybridoma tissue culture supernatant using protein
A–agarose affinity columns (Bioprocessing Ltd.), and
eluted with either 100 mM glycine (pH 3.0) and neutral-
ized with 1/10th vol 1.0 M Tris (pH 8.0) or with Pierce
ImmunoPure Gentle elution buffer (pH 7.0). After exten-
sive dialysis against PBS, 4 mg of purified 170/3 mAb
was mixed with 2 ml protein A–agarose beads for 1 h at
room temperature. Protein A–agarose beads bound to
170/3 mAb were washed twice with 10 vol of 0.2 M
sodium borate (pH 9.0) and resuspended in 10 vol of 0.2
M sodium borate (pH 9.0). Dimethylpimelimidate was
added to this slurry to a final concentration of 20 mM and
left to mix for 30 min at room temperature to covalently
couple 170/3 mAb to protein A–agarose beads. The re-
action was stopped by washing the beads in 0.2 M
ethanolamine (pH 8.0) and further incubating the beads
for 2 h at room temperature in 0.2 M ethanolamine (pH
8.0). The efficiency of binding was gauged by SDS–PAGE
of samples before and after coupling and Coomassie
blue staining for IgG heavy chain. Coupled 170/3 mAb–
protein A beads were stored at 4°C in PBS containing
0.01% sodium azide.
Purification of bacterially expressed Ad12 E1A 266-aa
protein on 170/3–protein A–agarose immunoaffinity col-
umns. Ad12 13S E1A cDNA was expressed in E. coli as
described above. Bacteria were lysed by sonication at
4°C, in either 50 mM sodium phosphate (pH 8.0), 300
mM NaCl or in 25 mM Tris (pH 8.0), 300 mM NaCl,
depending upon whether the final elution of E1A from
170/3–protein A–agarose affinity columns was with 100
mM glycine (pH 2.5) (phosphate compatible) or with the
Pierce buffer (not phosphate compatible). Bacterial ly-
sate containing Ad12 E1A 266-aa protein was incubated
with 170/3–protein A–agarose beads for 2 h at 4°C.
170/3–protein A–agarose beads with bound Ad12 13S
E1A were then extensively washed with the appropriate
lysis buffer containing 500 mM NaCl. Ad12 E1A was
subsequently eluted from 170/3–protein A immunoaffinity
columns using either 100 mM glycine (pH 2.5) or Pierce
elution buffer.
Preparation of Ad12 E1A binding proteins
Glutathione S-transferase–pRb (GST-pRb amino acids
379 to 928), GST-CtBP, GST-TBP, GST-SUG1, and GST-
HPV1 E4 (as a control) were expressed in E. coli. After
resuspension and sonication of bacteria in NETN buffer
(50 mM Tris–HCl, pH 8.0., 100 mM NaCl, 1 mM EDTA,
0.5% NP-40), insoluble material was removed by centrif-
ugation at 10K for 30 min and discarded. Supernatants
were incubated with glutathione–agarose beads (Sigma)
for 1.5 h at 4°C with constant agitation. After washing
with NETN buffer (three times) the agarose beads were
incubated for 30 min at 4°C with 5 mM glutathione. GST
fusion proteins were released into the supernatant and
the glutathione–agarose beads removed by centrifuga-
tion. After dialysis fusion proteins were stored at 270°C
until required.
Assay of Ad12 E1A binding proteins by ELISA
ELISAs for interaction of E1A with CtBP, SUG1, and
p105Rb. Plates were coated with purified Ad12 E1A or
chicken gizzard myosin phosphorylatable light chain (as
a control) [0.1 mg (3.5 pmol)/well] at 4°C overnight. Wells
were blocked with 5% skimmed milk in PBS at 37°C for
30 min. After washing (33) with PBS 0.1% Tween (PBST)
various dilutions of purified GST-CtBP, GST-SUG1 (0–10
mg), or GST-pRB (0–40 mg) were added and the plate was
incubated at 37°C for 1 h. After washing (33) with PBST,
bound GST fusion protein was detected by incubation for
1 h with goat polyclonal antibody against GST (200 ml
diluted 1:5000). The plates were washed again with
PBST (33) and incubated with HRP-linked anti-goat IgG
(1:1000, 200 ml) for 30 min at 37°C. After washing, HRP
substrate was added (100 ml of 0.4 mg/ml OPD in sodium
citrate, pH 5.0, containing 1 ml/ml H2O2) and the optical
density read at 405 nm using a BIO-TEK microtiter plate
reader. GST-HPV1E4 fusion protein was used as a con-
trol in these assays.
ELISAs for interaction of E1A with TBP and SUG1.
Plates were coated with purified GST-TBP or GST-SUG1
(0–10 mg 0–150 pmol and 0–130 pmol, respectively) over-
night at 4°C. Wells were blocked with 5% skimmed milk
in PBS at 37°C for 30 min. The plate was washed with
PBST (33). Purified Ad12 E1A was then added (2.5 mg/
well) and incubated at 37°C for 1 h. Bound E1A was
detected using the antibody 5DO2 (200 ml/well of a 1:10
dilution of monoclonal supernatant) at 37°C, followed by
HRP-linked anti-mouse IgG (1:1000, 200 ml). Color was
developed and plates were ‘‘read’’ as described above.
Nuclear magnetic resonance spectroscopy
Ad12 proteins (235 and 266 aa) were resuspended
from lyophilized powders in 25 mM [2H] Tris, adjusted
to pH 7.4 with [2H]Cl, and dialyzed exhaustively against
the same buffer. The final concentrations of proteins
were between 0.9 and 2.0 mg/ml. The influence of
Zn21 upon each protein was assessed by stepwise
titration of small (2 ml) volumes of 1 mM ZnCl2 (in 25
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mM [2H]Tris, pH 7.4) to give molar ratios of protein to
Zn21 of between 50:1 and 1:1.
All one-dimensional 1H NMR spectra were recorded
on a Bruker AMX500 spectrometer. A gated presatura-
tion pulse of 1.5 s (to remove H2O signal) was used for
accumulation over a 5050-Hz (10 ppm) sweep width with
a 90° pulse of 5 ms. Spectra were collected as free
induction decays (between 1024 and 2048 transients)
and Fourier transformed using a 2-Hz line broadening
function.
Limited proteolysis of Ad12 E1A
Purified 235- and 266-aa Ad12 E1A proteins were dis-
solved in 50 mM Tris–HCl, pH 7.9, 0.1 mM b-mercapto-
ethanol and incubated at 30°C. Chymotrypsin or V8 pro-
tease (Sigma) (1/1000:w/w) was added to initiate the
reaction. Aliquots were removed at appropriate times,
mixed with SDS–polyacrylamide gel electrophoresis
(PAGE) sample buffer, and fractionated on 15% SDS–
acrylamide gels. Ad12 E1A fragments were detected by
Western blotting using rat polyclonal Ad12 tumor bearer
sera or by staining of PVDF filters (Applied Biosystems)
with Ponceau S.
To examine binding of E1A partner proteins to the
Ad12 E1A proteolytic fragments, digests of the 266-aa
protein were fractionated on 15% polyacrylamide gels in
the presence of SDS and then electrophoretically trans-
ferred to nitrocellulose membranes. Membranes were
incubated in 5% skimmed milk powder in PBS for 1 h and
then in a solution of GST fusion protein (2.5 mg/ml) in 5%
milk powder in PBST. After 2 h blots were washed in
PBST (six times for at least 5 min each time) and then
incubated with an antibody (raised in goats) against GST
(1:2000 in 5% milk powder in PBST) for at least 1 h. Blots
were again washed in PBST and incubated in peroxi-
dase-linked anti-goat IgG (1:1000 in 5% milk in PBST) for
1 h. After repeated washing in PBST, GST fusion protein
was detected by ECL.
Antibodies
Ad12 E1A was detected with rat tumor bearer sera
(diluted 1/1000 for Western blotting), monoclonal anti-
body 5DO2 (diluted 1/10 for Western blotting), or with a
sheep polyclonal antibody (1/2000 for Western blots).
GST fusion proteins were detected with a polyclonal goat
serum (diluted 1/2000 for Western blots) from Pharmacia
Biotech.
Analytical methods
Amino acid analysis was carried out on peptides
blotted onto PVDF membranes using a custom-built
amino acid analyzer by Alta Bioscience (University of
Birmingham). Amino acid sequence analysis was also
carried out on peptides blotted onto PVDF membranes
using a Perkin–Elmer/ABI 473A sequencer by Alta
Bioscience (University of Birmingham). Five cycles
were performed on each peptide. PAGE was carried
out on 12 or 15% polyacrylamide gels (for proteins and
peptides, respectively) in the presence of 0.1 M Tris,
0.1 M bicine, 0.1% SDS. Proteins were generally trans-
ferred to nitrocellulose filters using standard proce-
dures. Following proteolytic digestion of Ad12 E1A the
fragments were electrophoresed on 15% polyacryl-
amide gels and then transferred to PVDF membranes
using the protocol recommended by the manufacturer
(Applied Biosystems).
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